Xponance LLC’s Abbott Laboratories Position
Does Xponance LLC own Abbott Laboratories (ABT)? Yes — 313.8K shares worth $32M (+0.23% of its 13F portfolio) as of Q1 2026, up from 274.2K shares the prior filed quarter.
Position Value
$32M
Q1 2026
Shares
313.8K
% of Portfolio
+0.23%
Quarters Held
24
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 313.8K | $32M | +0.23% |
| Q4 2025 | 274.2K | $34M | +0.26% |
| Q3 2025 | 258.6K | $35M | +0.27% |
| Q2 2025 | 289.9K | $39M | +0.33% |
| Q1 2025 | 274.3K | $36M | +0.35% |
| Q4 2024 | 268.7K | $30M | +0.28% |
| Q3 2024 | 242.5K | $28M | +0.27% |
| Q2 2024 | 239.5K | $25M | +0.25% |
| Q1 2024 | 250.6K | $28M | +0.30% |
| Q4 2023 | 235.9K | $26M | +0.31% |
| Q3 2023 | 218.1K | $21M | +0.29% |
| Q2 2023 | 214.4K | $23M | +0.31% |
| Q1 2023 | 234.2K | $24M | +0.35% |
| Q4 2022 | 235.9K | $26M | +0.42% |
| Q3 2022 | 202.0K | $20M | +0.38% |
| Q2 2022 | 176.8K | $19M | +0.39% |
| Q1 2022 | 232.2K | $27M | +0.46% |
| Q4 2021 | 202.7K | $29M | +0.45% |
| Q3 2021 | 178.1K | $21M | +0.40% |
| Q2 2021 | 200.9K | $23M | +0.43% |
| Q1 2021 | 207.4K | $25M | +0.53% |
| Q4 2020 | 208.1K | $23M | +0.50% |
| Q3 2020 | 206.0K | $22M | +0.55% |
| Q2 2020 | 188.5K | $17M | +0.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Xponance LLC’s full portfolio or all institutional holders of ABT.